Andrew Scheer on Questions Passed as Orders for Return

With regard to the Canadian Thalidomide Survivors Support Program: (a) how much has the government paid Epiq Class Action Services Canada Inc. related to the program to date; (b) how much is Epiq scheduled to be paid in each of the next five years; (c) how much has been paid out and to how many survivors through the program, broken down by year; (d) how many survivors receive ongoing payments, and what is the annual value of those payments; (e) for applications received between June 3, 1999 and June 3, 2024, how many applications (i) were received, (ii) were accepted, (iii) were denied, (iv) are still awaiting a decision; (f) of applications denied, what is the breakdown by reason for denial; (g) what audits or oversight has the government done on Epiq's administration of the program to ensure that value for money is being received; and (h) what was the average time between when an application was received and when a decision was made?